Filing Flows › Comparisons › SGHT vs IRMD
Sight Sciences vs Iradimed: SGHT and IRMD compared
Sight Sciences is the larger company: $24.9M of revenue in its latest quarter (Q3 2026) against $24.2M for Iradimed (Q3 2026). Sight Sciences is growing faster (+25% against +14% a year earlier). Iradimed is more profitable, with an operating margin of 33.6% against -24.6%.
Where the money goes: SGHT and IRMD
Sight Sciences (SGHT) · Q3 2026
Sight Sciences, Q3 2026: revenue $24.9M (+25% year over year), operating margin -24.6%, net loss $6.8M, operating cash flow −$2.4M. The chart follows the revenue to costs, profit and cash.
Iradimed (IRMD) · Q3 2026
Iradimed, Q3 2026: revenue $24.2M (+14% year over year), operating margin 33.6%, net earnings $6.5M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.
| Sight Sciences (SGHT) | Iradimed (IRMD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $24.9M | $24.2M |
| Revenue growth, Y/Y | +25% | +14% |
| Gross margin | — | 76.3% |
| Operating margin | -24.6% | 33.6% |
| Net earnings | −$6.8M | $6.5M |
| Net margin | -27.3% | 26.9% |
| Operating cash flow | −$2.4M | $7.0M |
| Free cash flow | — | $6.8M |
| Market value | — | $1.1B |
| P/E | — | 46.8× |
| Analysts’ mean target | — | $118.00 |
Where the revenue comes from
Sight Sciences
- Surgical Glaucoma: $21.0M (84%)
- Dry Eye: $3.9M (16%)
Iradimed
- Total devices revenue: $17.2M (71%)
- Disposables: $5.0M (21%)
- Services and other: $1.2M (5%)
- Amortized Revenue: $801K (3%)
Questions
Which is bigger, Sight Sciences or Iradimed?
Sight Sciences is the larger company: $24.9M of revenue in its latest quarter (Q3 2026) against $24.2M for Iradimed (Q3 2026).
Is Sight Sciences or Iradimed growing faster?
Sight Sciences is growing faster (+25% against +14% a year earlier).
Which is more profitable, Sight Sciences or Iradimed?
Iradimed is more profitable, with an operating margin of 33.6% against -24.6%.
More: Sight Sciences earnings · how Sight Sciences makes money · Iradimed earnings · how Iradimed makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Oct 30, 2026). Fiscal quarters can end on different dates. Not investment advice.